6 FEC 100 Vs 4 FEC 100 Followed by 4 Taxol in N+ Breast Cancer

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2005
The main objective of this randomized trial is to compare 6 FEC100 to 4 FEC100 + 4 Taxol in patients with resected node positive breast cancer. Main endpoint is disease free survival. Secondary endpoints are overall survival, time to local recurrence, time to distant metastases, and tolerance. A total of 840 patients have been included in the trial.
Epistemonikos ID: 7b583f51bc6559295fba54aa0c23fb92bef098a9
First added on: May 04, 2024